Robotic versus laparoscopic gastrectomy

Surgical Endoscopy

Volumn 24, Issue 1, 2010, Pages 239-241

  Hanisch, Ernst ^a   Ziogas, Dimosthenis ^b  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b UNIVERSITY OF IOANNINA   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURGERY; CLINICAL COMPETENCE; COLORECTAL CANCER; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; EVIDENCE BASED MEDICINE; GASTRECTOMY; HIGH RISK PATIENT; LAPAROSCOPIC SURGERY; LENGTH OF STAY; LYMPH NODE DISSECTION; LYMPHADENECTOMY; OPERATION DURATION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RECTUM CANCER; RISK ASSESSMENT; ROBOTICS; SAFETY; SHORT SURVEY;

EID: 74149092909     PISSN: 09302794     EISSN: 14322218     Source Type: Journal    
DOI: 10.1007/s00464-009-0625-x     Document Type: Short Survey

References (37)

1. E Kuhry W Schwenk R Gaupset U Romild J Bonjer 2008 Long-term outcome of laparoscopic surgery for colorectal cancer: a Cochrane systematic review of randomised controlled trials Cancer Treat Rev 34 498 504 10.1016/j.ctrv.2008.03. 011 18468803
2. D Ziogas A Polychronidis I Kanellos D Roukos 2009 Laparoscopic colectomy survival benefit for colon cancer: is evidence from a randomized trial true? Ann Surg 249 695 696 10.1097/SLA.0b013e31819f26e9 19300211
3. T Liakakos D Roukos 2008 Laparoscopic gastrectomy: advances enable wide clinical application Surg Endosc 22 1553 1555 10.1007/s00464-008-9869-0 1:STN:280:DC%2BD1czgvFOnuw%3D%3D 18401654
4. D Ziogas D Roukos 2008 Robotic surgery for rectal cancer: may it improve also survival? Surg Endosc 22 1405 1406 10.1007/s00464-008-9796-0 18320279
5. Song J, Kang WH, Oh SJ, Hyung WJ, Choi SH, Noh SH (2009) Role of robotic gastrectomy using da Vinci system compared with laparoscopic gastrectomy: initial experience of 20 consecutive cases. Surg Endosc 23(6):1204-1211
6. DH Roukos P Paraschou M Lorenz 2000 Distal gastric cancer and extensive surgery: a new evaluation method based on the study of the status of residual lymph nodes after limited surgery Ann Surg Oncol 7 719 726 10.1007/s10434-000- 0719-0 1:STN:280:DC%2BD3M7gsV2nsw%3D%3D 11129418
7. DH Roukos AM Kappas 2002 Targeting the optimal extent of lymph node dissection for gastric cancer J Surg Oncol 81 59 62 10.1002/jso.10153 12355403
8. AM Kappas M Fatouros DH Roukos 2004 Is it time to change surgical strategy for gastric cancer in the United States? Ann Surg Oncol 11 727 730 10.1245/ASO.2004.05.907 15249337 (Pubitemid 40486685)
9. DH Roukos 1998 Extended lymphadenectomy in gastric cancer: when, for whom and why Ann R Coll Surg Engl 80 16 24 1:STN:280:DyaK1c3ktVartw%3D%3D 9579122
10. DH Roukos 2000 Extended (D2) lymph node dissection for gastric cancer: do patients benefit? Ann Surg Oncol 7 253 255 10.1007/s10434-000-0253-0 1:STN:280:DC%2BD3c3nslGitg%3D%3D 10819363
11. DH Roukos C Hottenrott M Lorenz S Koutsogiorgas-Couchell 1990 A critical evaluation of effectivity of extended lymphadenectomy in patients with carcinoma of the stomach: an analysis of early results and long-term survival J Cancer Res Clin Oncol 116 307 311 10.1007/BF01612909 1:STN:280:DyaK3czhs12nsA%3D%3D 2370254 (Pubitemid 20299176)
12. AM Kappas DH Roukos 2002 Quality of surgery determinant for the outcome of patient with gastric cancer Ann Surg Oncol 9 828 830 10.1007/BF02557517 12417502
13. Roukos DH (2009) Personalized cancer diagnostics and therapeutics. Expert Rev Mol Diagn 9(3):227-229
14. DH Roukos C Hottenrott A Encke G Baltogiannis D Casioumis 1994 Primary gastric lymphomas: a clinicopathologic study with literature review Surg Oncol 3 115 125 10.1016/0960-7404(94)90007-8 1:STN:280:DyaK2M%2FktVWitQ%3D%3D 7952391 (Pubitemid 24237139)
15. DH Roukos 2004 Early-stage gastric cancer: a highly treatable disease Ann Surg Oncol 11 127 129 10.1245/ASO.2004.11.903 14761914 (Pubitemid 40486786)
16. E Briasoulis M Fatouros DH Roukos 2007 Level I evidence in support of perioperative chemotherapy for operable gastric cancer: sufficient for wide clinical use? Ann Surg Oncol 14 2691 2695 17653806
17. E Briasoulis T Liakakos L Dova M Fatouros P Tsekeris DH Roukos AM Kappas 2006 Selecting a specific pre- or postoperative adjuvant therapy for individual patients with operable gastric cancer Expert Rev Anticancer Ther 6 931 939 10.1586/14737140.6.6.931 16761937 (Pubitemid 44201562)
18. Roukos DH (2009) Mea Culpa with cancer-targeted therapy: new thinking and new agents design for novel, causal networks-based, personalized biomedicine. Expert Rev Mol Diagn 9(3):217-221
19. DH Roukos 2009 Genome-wide association studies and aggressive surgery toward individualized prevention, and improved local control and overall survival for gastric cancer Ann Surg Oncol 16 795 798 10.1245/s10434-009-0317-8 19169753
20. T Liakakos DH Roukos 2008 More controversy than ever: challenges and promises towards personalized treatment of gastric cancer Ann Surg Oncol 15 956 960 10.1245/s10434-007-9798-5 18214617
21. DH Roukos M Lorenz K Karakostas P Paraschou C Batsis AM Kappas 2001 Pathological serosa and node-based classification accurately predicts gastric cancer recurrence risk and outcome, and determines potential and limitation of a Japanese-style extensive surgery for Western patients: a prospective with quality control 10-year follow-up study Br J Cancer 84 1602 1609 10.1054/bjoc.2001.1720 1:STN:280:DC%2BD3MzjsVSgtA%3D%3D 11401312 (Pubitemid 32612490)
22. DH Roukos 2009 Assessing both genetic variation (SNPs/CNVs) and gene-environment interactions may lead to personalized gastric cancer prevention Expert Rev Mol Diagn 9 1 6 10.1586/14737159.9.1.1 1:CAS:528:DC%2BD1cXhsFajsrnE 19099341
23. D Ziogas G Baltogiannis M Fatouros DH Roukos 2008 Identifying and preventing high-risk gastric cancer individuals with CDH1 mutations Ann Surg 247 714 715 10.1097/SLA.0b013e31816a5072 18362641
24. DH Roukos 2008 Linking contralateral breast cancer with genetics Radiother Oncol 86 139 141 10.1016/j.radonc.2008.01.013 18237805
25. M Fatouros G Baltogiannis DH Roukos 2008 The predominant role of surgery in the prevention and new trends in the surgical treatment of women with BRCA1/2 mutations Ann Surg Oncol 15 21 33 10.1245/s10434-007-9612-4 17940826
26. NJ Agnantis E Paraskevaidis D Roukos 2004 Preventing breast, ovarian cancer in BRCA carriers: rational of prophylactic surgery and promises of surveillance Ann Surg Oncol 11 1030 1034 10.1245/ASO.2004.09.910 15545500 (Pubitemid 40486647)
27. DH Roukos 2009 Radiation therapy for breast cancer N Engl J Med 360 1362 1363 10.1056/NEJMc090162 1:CAS:528:DC%2BD1MXjs1Sgsbo%3D 19330940
28. DH Roukos 2009 Twenty-one-gene assay: challenges and promises in translating personal genomics and whole-genome scans into personalized treatment of breast cancer J Clin Oncol 27 1337 1338 10.1200/JCO.2008.20.2812 19188673
29. DH Roukos 2008 Genetics and genome-wide association studies: surgery-guided algorithm and promise for future breast cancer personalized surgery Expert Rev Mol Diagn 8 587 597 10.1586/14737159.8.5.587 18785807
30. DH Roukos 2009 Personal genomics and genome-wide association studies: novel discoveries but limitations for practical personalized medicine Ann Surg Oncol 16 772 773 10.1245/s10434-008-0109-6 18726130
31. M Fatouros DH Roukos I Arampatzis A Sotiriadis E Paraskevaidis AM Kappas 2005 Factors increasing local recurrence in breast-conserving surgery Expert Rev Anticancer Ther 5 737 745 10.1586/14737140.5.4.737 16111473 (Pubitemid 41223280)
32. DH Roukos D Ziogas 2009 Human genetic and structural genomic variation: would genome-wide association studies be the solution for cancer complexity like Alexander the Great for the "Gordian Knot"? Ann Surg Oncol 16 774 775 10.1245/s10434-008-0056-2 18612696
33. DH Roukos 2008 Breast-cancer stromal cells with TP53 mutations N Engl J Med 358 1636 10.1056/NEJMc073152 1:CAS:528:DC%2BD1cXks1Wjtbc%3D 18411428
34. DH Roukos AM Kappas NJ Agnantis 2003 Perspectives and risks of breast-conservation therapy for breast cancer Ann Surg Oncol 10 718 721 10.1245/ASO.2003.05.925 12900361 (Pubitemid 40486870)
35. Roukos DH (2009) Breast cancer outcomes: the crucial role of the breast surgeon in the era of personal genetics and systems biology. Ann Surg 249(6):1067-1068
36. Ziogas D, Roukos DH (2009) Genetics and personal genomics for personalized breast cancer surgery: progress and challenges in research and clinical practice. Ann Surg Oncol 16(7):1771-1782
37. Roukos DH (2009) Genome-wide association studies: how predictable is a person's cancer risk? Expert Rev Anticancer Ther 9(4):389-392